Abstract
Purpose Thermal dose-effect relations have demonstrated that clinical effectiveness of hyperthermia would benefit from more controlled heating of the tumor. Hyperthermia treatment planning (HTP) is a potent tool to study strategies enabling target conformal heating, but its accuracy is affected by patient modeling approximations. Homogeneous phantoms models are being used that do not match the body shape of patients in treatment position and often have unrealistic target volumes. As a consequence, simulation accuracy is affected, and performance comparisons are difficult. The aim of this study is to provide the first step toward standardization of HTP simulation studies in terms of patient modeling by introducing the Erasmus Virtual Patient Repository (EVPR): a virtual patient model database. Methods Four patients with a tumor in the head and neck or the pelvis region were selected, and corresponding models were created using a clinical segmentation procedure. Using the Erasmus University Medical Center standard procedure, HTP was applied to these models and compared to HTP for commonly used surrogate models. Results Although this study was aimed at presenting the EVPR database, our study illustrates that there is a non-negligible difference in the predicted SAR patterns between patient models and homogeneous phantom-based surrogate models. We further demonstrate the difference between actual and simplified target volumes being used today. Conclusion Our study describes the EVPR for the research community as a first step toward standardization of hyperthermia simulation studies.
Highlights
Clinical and biological studies have shown the benefit of hyperthermia as an additive to radiotherapy and chemotherapy [1,2,3,4,5]
A trained clinician identified the hyperthermia target volume (HTV) starting from the clinical target volume (CTV) for radiotherapy treatment and adding certain margins depending on the specific case [49,50]
We considered target coverage above 25% and 50% of the maximum and we indicated these as TC25 and TC50, respectively
Summary
Clinical and biological studies have shown the benefit of hyperthermia as an additive to radiotherapy and chemotherapy [1,2,3,4,5]. In HTP simulation studies, it is common practice to use computer-aided design (CAD) models of healthy volunteers and homogeneous phantoms with anatomical shapes [12,13,14,15,16,17,18,19]. These models, while readily available, often are not representative of the hyperthermia patient models in terms of anatomy, posture and target shape. Comparisons amongst different studies are difficult and of questionable relevance because of the different models being used
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.